TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 249 filers reported holding TG THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,952 | -66.3% | 353 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $8,769 | +65.1% | 353 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $5,310 | +27.2% | 353 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,176 | +108.8% | 353 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $2,000 | 0.0% | 353 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,000 | -33.3% | 353 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $3,000 | -57.1% | 353 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $7,000 | -41.7% | 353 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $12,000 | -14.3% | 353 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | -17.6% | 353 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $17,000 | +70.0% | 353 | +81.0% | 0.00% | +33.3% |
| Q4 2020 | $10,000 | +100.0% | 195 | 0.0% | 0.00% | +200.0% |
| Q3 2020 | $5,000 | +25.0% | 195 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | +100.0% | 195 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | – | 195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 1,647,000 | $6,423,000 | 0.45% |
| DAFNA Capital Management LLC | 75,000 | $293,000 | 0.30% |
| Baker Brothers Advisors | 2,199,656 | $8,579,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 71,105 | $277,000 | 0.05% |
| SMITH ASSET MANAGEMENT GROUP LP | 196,684 | $767,000 | 0.03% |
| SABBY MANAGEMENT, LLC | 66,000 | $257,000 | 0.02% |
| THOMPSON DAVIS & CO., INC. | 1,000 | $4,000 | 0.01% |
| COLUMBUS CIRCLE INVESTORS | 161,919 | $631,000 | 0.00% |
| JENNISON ASSOCIATES LLC | 455,271 | $1,776,000 | 0.00% |
| BlackRock Fund Advisors | 448,445 | $1,749,000 | 0.00% |